This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
6. WL Atkinson , NH Arden , PA Patriarca N Leslie , KJ Lui , R Gohd . Amantadine prophylaxis during an institutional outbreak of type A (H1N1) influenza. Arch Intern Med 1986;146:1751–1756.
8. J Degelau , SK Somani SL Cooper , DR Guay , KB Crossley . Amantadine-resistant influenza A in a nursing facility. Ardi Intern Med 1992;152:390–392.
9. P Houck , M Hemphill , S LaCroix , D Hirsh , N Cox . Amantadine-resistant influenza A in a nursing homes. Identification of a resistant virus prior to drug use. Arch Intern Med 1995;155:533–537.
10. FG Hayden , AD Osterhaus , JJ Treanor , DM Fleming , FY Aoki , KG Nicholson , et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med 1997;337:874–880.
12. AS Monto , DP Robinson , ML Herlocher , JM Hinson Jr, MJ Elliott , A Crisp Zanamivir in the prevention of influenza among healthy adults: a randomized controlled txial. JAMA 1999;282:31–35.
13. M Schilling , L Povinelli , P Krause , M Gravenstein , Ambrozaitis A HH Jones , et al. Efficacy of zanamivir for chemoprophylaxis of nursing home outbreaks. Vaccine 1998;16:1771–1774.
14. A McGeer , B Campbell , TG Emori , WJ Hierholzer , MM Jackson , LE Nicolle , et al. Definitions of infection for surveillance in long-term care facilities. Am J Infect Control 1991;19:1–7.
15. S Katz , TD Downs , HR Cash , RD Frotz . Progress in the development of the index of ADL. Gerontologist 1970;10:20–30.
18. PA Patriarca JA Weber RA Parker WN Hall , AP Kendal , DJ Bregman , et al. Efficacy of influenza vaccines in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA 1985;253:1136–1139.
20. J Potter , DJ Stott , MA Roberts AG Elder , B O'Donnell , PV Knight , et al. Influenza vaccination of health care workers in long-term-care hospitals reduces mortality of elderly patients. J Infect Dis 1997;175:1–6.
21. WF Carman , AG Elder , LA Wallace , K McAulay , Walker A GD Murray , et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 2000;355:93–97.
22. TM Goevart , CT Thijs , N Masurel , JJ Sprenger , GJ Dinant , JA Knottnerus The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994;272:1661–1665.
23. PA Gross AW Hermogenes , HS Sacks , J Lau , RA Levandowski The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995;123:518–527.
24. MA Strassburg , S Greenland , FJ Sondilo , LE Lieb , LA Habel Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine 1986;4:38–44.
25. SE Ohmit , NH Arden , AS Monto . Effectiveness of inactivated influenza vaccine among nursing home residents during an influenza type A (H3N2) epidemic. J Am Geriatr Soc 1999;47:165–71.
27. R Dolin , RC Reichman , HP Madore , R Maynard , PN Linton , J Webber-Jones . A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 1982;307:580–584.
28. FG Hayden . Antivirals for pandemic influenza. J Infect Dis 1997;176(suppl 1):S56–S61.
29. NH Arden , PA Patriarca , MB Fasano , KJ Lui , MW Harmon , AP Kendal , et al. The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Arch Intern Med 1988;148:865–868.
30. NL Peters , S Oboler , C Hair , L Laxson , J Kost , G Meiklejohn . Treatment of an influenza A outbreak in a teaching nursing home. Effectiveness of a protocol for prevention and control. J Am Geriatr Soc 1989;37:210–218.
32. HG Hayden , RB Belshe , RD Clover , AJ Hay , MJ Oakes , W Soo . Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med 1989;321:1696–1702.
33. FG Hayden , RL Atmar , M Schilling , C Johnson , D Poretz , D Paar , et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999;341:1336–1343.
35. LV Gubareva , L Kaiser , FG Hayden . Influenza virus neuraminidase inhibitors. Lancet 2000;355:827–835.